chr7-152823439-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_020445.6(ACTR3B):c.782C>T(p.Ala261Val) variant causes a missense change. The variant allele was found at a frequency of 0.000478 in 1,614,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00049 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00048 ( 0 hom. )
Consequence
ACTR3B
NM_020445.6 missense
NM_020445.6 missense
Scores
2
17
Clinical Significance
Conservation
PhyloP100: 3.90
Genes affected
ACTR3B (HGNC:17256): (actin related protein 3B) This gene encodes a member of the actin-related proteins (ARP), which form multiprotein complexes and share 35-55% amino acid identity with conventional actin. The protein encoded by this gene may have a regulatory role in the actin cytoskeleton and induce cell-shape change and motility. Pseudogenes of this gene are located on chromosomes 2, 4, 10, 16, 22 and Y. Alternative splicing results in multiple transcript variants and protein isoforms. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.021694511).
BS2
High AC in GnomAd4 at 75 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACTR3B | NM_020445.6 | c.782C>T | p.Ala261Val | missense_variant | 8/12 | ENST00000256001.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACTR3B | ENST00000256001.13 | c.782C>T | p.Ala261Val | missense_variant | 8/12 | 1 | NM_020445.6 | P1 | |
ACTR3B | ENST00000377776.7 | c.782C>T | p.Ala261Val | missense_variant | 8/10 | 1 | |||
ACTR3B | ENST00000397282.2 | c.518C>T | p.Ala173Val | missense_variant | 7/11 | 2 | |||
ACTR3B | ENST00000479402.1 | n.4250C>T | non_coding_transcript_exon_variant | 4/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000493 AC: 75AN: 152194Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
75
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000577 AC: 145AN: 251470Hom.: 0 AF XY: 0.000581 AC XY: 79AN XY: 135906
GnomAD3 exomes
AF:
AC:
145
AN:
251470
Hom.:
AF XY:
AC XY:
79
AN XY:
135906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000476 AC: 696AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.000466 AC XY: 339AN XY: 727248
GnomAD4 exome
AF:
AC:
696
AN:
1461884
Hom.:
Cov.:
31
AF XY:
AC XY:
339
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000492 AC: 75AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.000564 AC XY: 42AN XY: 74490
GnomAD4 genome
AF:
AC:
75
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
42
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
64
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.782C>T (p.A261V) alteration is located in exon 8 (coding exon 8) of the ACTR3B gene. This alteration results from a C to T substitution at nucleotide position 782, causing the alanine (A) at amino acid position 261 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;B;.
Vest4
MVP
MPC
0.94
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at